Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.12 - $1.57 $173,288 - $242,913
154,722 Added 4.32%
3,734,799 $5.53 Million
Q4 2023

Feb 14, 2024

BUY
$0.72 - $1.56 $54,998 - $119,163
76,387 Added 2.18%
3,580,077 $5.19 Million
Q3 2023

Nov 14, 2023

SELL
$1.07 - $1.39 $21,961 - $28,529
-20,525 Reduced 0.58%
3,503,690 $3.78 Million
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.82 $87,427 - $142,069
78,060 Added 2.27%
3,524,215 $4.55 Million
Q1 2023

May 15, 2023

BUY
$1.25 - $2.0 $89,051 - $142,482
71,241 Added 2.11%
3,446,155 $4.55 Million
Q4 2022

Feb 14, 2023

SELL
$0.67 - $11.9 $337,111 - $5.99 Million
-503,152 Reduced 12.97%
3,374,914 $5.06 Million
Q3 2022

Nov 15, 2022

SELL
$1.1 - $12.2 $22.1 Million - $245 Million
-20,067,502 Reduced 83.8%
3,878,066 $4.58 Million
Q2 2022

Aug 15, 2022

BUY
$0.67 - $3.19 $11 Million - $52.4 Million
16,421,362 Added 218.25%
23,945,568 $27.1 Million
Q1 2022

May 16, 2022

SELL
$2.22 - $3.45 $2.31 Million - $3.59 Million
-1,041,604 Reduced 12.16%
7,524,206 $22.5 Million
Q4 2021

Feb 14, 2022

SELL
$2.36 - $3.57 $313,004 - $473,485
-132,629 Reduced 1.52%
8,565,810 $22.7 Million
Q3 2021

Nov 15, 2021

SELL
$3.5 - $4.5 $6.98 Million - $8.97 Million
-1,993,485 Reduced 18.64%
8,698,439 $31.6 Million
Q2 2021

Aug 16, 2021

SELL
$3.09 - $4.54 $5.64 Million - $8.28 Million
-1,824,801 Reduced 14.58%
10,691,924 $46.4 Million
Q1 2021

May 17, 2021

BUY
$3.35 - $4.93 $10.6 Million - $15.6 Million
3,154,221 Added 33.69%
12,516,725 $42.8 Million
Q4 2020

Feb 16, 2021

SELL
$2.35 - $3.74 $1.75 Million - $2.78 Million
-743,841 Reduced 7.36%
9,362,504 $32.8 Million
Q3 2020

Nov 10, 2020

BUY
$1.78 - $4.13 $11.6 Million - $27 Million
6,542,643 Added 183.59%
10,106,345 $24.3 Million
Q2 2020

Aug 14, 2020

BUY
$1.41 - $2.05 $19,830 - $28,831
14,064 Added 0.4%
3,563,702 $6.52 Million
Q1 2020

May 11, 2020

BUY
$1.27 - $3.0 $4.51 Million - $10.6 Million
3,549,638 New
3,549,638 $5.54 Million

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.